Skip to content
  • Thursday, 25 June 2026
  • 9:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials
Laboratory Automation & Robotics

Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials

Lana Keisha Jun 25, 2026 0

INDIANAPOLIS, IN – Eli Lilly and Company has announced groundbreaking Phase 3 trial results for its investigational drug, retatrutide, a…

Read More
Creating early career opportunities for advanced therapy manufacturing and developmentTWiV 1288: Clinical update with Dr. Daniel GriffinGlioblastoma Immune Cells Hijack Fructose Metabolism to Suppress Anti-Tumor Responses, Unveiling a Novel Therapeutic Pathway.TWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Understanding Osteopenia: The Silent Global Health Crisis of Bone Density Loss and the Roadmap to PreventionAI & Antibodies miniseries | Designing smart antibodies in the age of AIEli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 TrialsMonash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Understanding Osteopenia: The Silent Global Health Crisis of Bone Density Loss and the Roadmap to Prevention
Dwi Wanna Jun 25, 2026
Biotech & Genetic Research
AI & Antibodies miniseries | Designing smart antibodies in the age of AI
Jia Lissa Jun 25, 2026
Laboratory Automation & Robotics
Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials
Lana Keisha Jun 25, 2026
Neuroscience & Brain Research
Monash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems
Rifan Muazin Jun 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ